Lenalidomide promotes the development of <i>TP53</i>-mutated therapy-related myeloid neoplasmsAdam S. Sperling, Koichi Takahashi, Rashmi Kanagal‐Shamanna et al.|Blood|2022Cited by 138
PPM1D in Solid and Hematologic Malignancies: Friend <i>and</i> Foe?Linda Zhang, Margaret A. Goodell, Joanne I. Hsu|Molecular Cancer Research|2022Cited by 24
<i>SOD1</i> is a synthetic lethal target in <i>PPM1D</i> -mutant leukemia cellsLinda Zhang, Margaret A. Goodell, Sarah M. Waldvogel et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 2
SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cellsLinda Zhang, Margaret A. Goodell, Sarah M. Waldvogel et al.|eLife|2023Cited by 1
Author Correction: Clonal evolution of hematopoietic stem cells after autologous stem cell transplantationHidetaka Uryu, Koichi Takahashi, Farhad Ravandi et al.|Nature Genetics|2025Cited by 1